ES2321589T3
(es )
2009-06-09
Composicion farmaceutica antiabuso que contiene capsaicina.
CY1115766T1
(el )
2017-01-25
Καθαρισμος και σταθεροποιηση πεπτιδιου και πρωτεϊνων σε φαρμακευτικους παραγοντες
KR19990044182A
(ko )
1999-06-25
말초 활성 통각과민 치료용 아편제
CA2434484A1
(en )
2002-07-25
Compositions comprising ibuprofen and diphenhydramine to treat pain-associated sleep disturbances
JP2002529411A
(ja )
2002-09-10
イオン性銀錯体
RU2009148288A
(ru )
2011-06-27
Профилактическое или терапевтическое средство для возрастной дегенерации желтого пятна
ATE146677T1
(de )
1997-01-15
Pharmazeutische formulierung zur behandlung der nicotinabhängigkeit
US20250319074A1
(en )
2025-10-16
Treatment and management of augmentation in restless legs syndrome
SG146638A1
(en )
2008-10-30
Pharmaceutical delivery system
WO2001030380A3
(en )
2001-11-01
Methods and compositions for treatment of keratoconus using protease inhibitors
PT1656131E
(pt )
2011-06-07
Utilização de betaína para tratar claudicação intermitente
SE8304616D0
(sv )
1983-08-25
Retinaskyddsmedel for behandling av intraokulera blodningar, myopiska korioretinala dystrofier, medfodda retinadystrofier och retinabrennsar samt for forebyggande av skador vid laserkoagulering
WO2002064552A8
(en )
2002-12-12
1g(a)-AMINO-N-HYDROXY-ACETAMIDE DERIVATIVES
TW200616644A
(en )
2006-06-01
Medicine for prevention or treatment of diabetes
Matochik et al.
1992
Regulation of sociosexual communication in female Long-Evans rats by ovarian hormones
TH65541A
(https= )
2004-12-16
ATE333897T1
(de )
2006-08-15
Arzneimittel mit chymaseinhibitoren als wirksames mittel zur behandlung von dermatitis mit zweiphasigen hautreaktionen
Goultschin et al.
1986
Inhibition of Superoxide generation by human polymorphonuclear leukocytes with chlorhexidine: its possible relation to periodontal disease
Sharma et al.
1997
Nonencapsulated, intact omeprazole granules effectively suppress intragastric acidity when administered via a gastrostomy.
US10413523B2
(en )
2019-09-17
Enkephalin-influencing composition and method
ES2285995T3
(es )
2007-12-01
Combinacion para el tratamiento de la depresion y ansiedad que contiene un antagonista del receptor de nk-1 que penetra en el snc y un agente antidepresivo o ansiolitico.
AU2020417185B2
(en )
2026-03-12
Composition and therapy for treatment of gag reflexes
AU2007327538B2
(en )
2013-07-04
Treatment for envenomation
MXPA04011560A
(es )
2005-06-08
Formulacion anti-cancer.
JPH0649646B2
(ja )
1994-06-29
中枢性鎮痛剤の耐薬性発現抑制剤